ReviewFuture microbiology2026
Evolution and rise of antimicrobial resistance in key public health bacteria within and across the One Health sectors.
Review in Future microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Antimicrobial Resistance at the Human-Animal-Environment Interface: A One Health Perspective on Drivers, Transmission, and Public Health Responses.Health science reports · 2026Article
- ESBL and carbapenemase-producing enteric pathogens in animal-origin foods: a one health perspective.Folia microbiologica · 2026Review
- Patterns, Associated Factors, and Anatomical Concordance of Nasal and ThroatMicroorganisms · 2026Article
- Editorial: Phage-based interventions in livestock: from genomics to translational applications.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance (AMR) poses a significant threat to global health and exerts an increasing economic burden on healthcare systems worldwide. Understanding AMR in human pathogens requires discernment of the complex interactions within the One Health continuum that encompasses humans, animals, and the environment. The issue extends beyond antibiotic misuse in medicine to include a broad spectrum of sector activities that contribute to the development and spread of ressitance genes; veterinary practice, farming, agriculture, aquaculture, and industrial operations. Emerging bacterial resistance within pathogens of public health importance are examined from the One Health perspective, focusing on the mechanisms of genetic change that enable resistance. AMR in specific bacteria particularly important due to the transmissibility of these pathogens amongst individuals, nosocomial environments, and the population leading to the resurgence of diseases that were previously controlled. Advanced genomic typing methods enhance the ability to delineate bacterial strains, improving surveillance and monitoring efforts. Recognizing the interconnectedness of human, animal, and environmental health is vital for safeguarding the effectiveness of antibiotics. Coordinated action across all sectors within the One Health framework is essential to preserve these critical drugs for future generations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.